Dual 5-alpha Reductase Inhibitor
Approved for Benign Prostatic Hyperplasia (BPH)
Phase III trials for hair loss believed resumed – Supplemental New Drug Application for Hair loss may be submitted to FDA
Much greater and longer inhibition of DHT than Propecia in early testing.
The big question will be is it better than Propecia and whether side effects will be greater or more serious. Currently approved form will be a 0.5 mg soft gel.